AGL 37.99 Decreased By ▼ -0.03 (-0.08%)
AIRLINK 215.53 Increased By ▲ 18.17 (9.21%)
BOP 9.80 Increased By ▲ 0.26 (2.73%)
CNERGY 6.79 Increased By ▲ 0.88 (14.89%)
DCL 9.17 Increased By ▲ 0.35 (3.97%)
DFML 38.96 Increased By ▲ 3.22 (9.01%)
DGKC 100.25 Increased By ▲ 3.39 (3.5%)
FCCL 36.70 Increased By ▲ 1.45 (4.11%)
FFBL 88.94 No Change ▼ 0.00 (0%)
FFL 14.49 Increased By ▲ 1.32 (10.02%)
HUBC 134.13 Increased By ▲ 6.58 (5.16%)
HUMNL 13.63 Increased By ▲ 0.13 (0.96%)
KEL 5.69 Increased By ▲ 0.37 (6.95%)
KOSM 7.32 Increased By ▲ 0.32 (4.57%)
MLCF 45.87 Increased By ▲ 1.17 (2.62%)
NBP 61.28 Decreased By ▼ -0.14 (-0.23%)
OGDC 232.59 Increased By ▲ 17.92 (8.35%)
PAEL 40.73 Increased By ▲ 1.94 (5%)
PIBTL 8.58 Increased By ▲ 0.33 (4%)
PPL 203.34 Increased By ▲ 10.26 (5.31%)
PRL 40.81 Increased By ▲ 2.15 (5.56%)
PTC 28.31 Increased By ▲ 2.51 (9.73%)
SEARL 108.51 Increased By ▲ 4.91 (4.74%)
TELE 8.74 Increased By ▲ 0.44 (5.3%)
TOMCL 35.83 Increased By ▲ 0.83 (2.37%)
TPLP 13.84 Increased By ▲ 0.54 (4.06%)
TREET 24.38 Increased By ▲ 2.22 (10.02%)
TRG 61.15 Increased By ▲ 5.56 (10%)
UNITY 34.84 Increased By ▲ 1.87 (5.67%)
WTL 1.72 Increased By ▲ 0.12 (7.5%)
BR100 12,244 Increased By 517.6 (4.41%)
BR30 38,419 Increased By 2042.6 (5.62%)
KSE100 113,924 Increased By 4411.3 (4.03%)
KSE30 36,044 Increased By 1530.5 (4.43%)

The United States on Friday announced it was funding development of rapid diagnostic kits for the novel coronavirus as people across the country reported they were unable to get tested for the illness because of shortages.

US authorities have come under fire for lagging behind in deploying test kits, which leading health experts have said allowed the virus to spread beyond the country's ability to detect it. The Department of Health and Human Services (HHS) said Friday it was providing almost $1.3 million in funding to two labs to develop tests that return results in about one hour. At present results generally take several days.

The HHS said it was providing almost $700,000 to DiaSorin Molecular of California and just under $600,000 to QIAGEN of Maryland to develop the tests, but provided no timeline about when these would be available.

As of Friday morning there were more than 1,700 confirmed US cases and 40 deaths, according to a Johns Hopkins University tracker. At the start of the outbreak testing was only occurring at the headquarters of the Centers for Disease Control (CDC). The CDC then started sending its kits out to state labs, but the first batches were faulty and had to be modified.

Regulatory hurdles meant that state authorities were prevented from developing and using their own tests based on protocols provided by the World Health Organization.

These roadblocks were finally lifted on February 29, a month after the first US case, and private laboratories including major players LabCorp and Quest have announced their kits have entered the market.

But on the ground, people are still reporting they are unable to be tested - even when clinical signs suggest they have the pathogen. Earlier this week Vice President Mike Pence said that through a combination of government and private efforts a million test kits had now been deployed and millions more were on the way - figures that were later revealed to be misleading because these kits still lack vital components to activate them.

Copyright Agence France-Presse, 2020

Comments

Comments are closed.